Objectives {7}
death, silicone foam
SECONDARY
The primary objectives of the EEPOC trial are to:Determine the clinical and cost-effectiveness of a prophylactic silicone foam border dressing in preventing sacral hospital-acquired pressure injuries (HAPI) in hospitalised patients assessed at risk for PIDescribe the characteristics and clinical care received by patients who develop a sacral HAPI up to 14 days, or until hospital discharge or death after PI occurrenceUnderstand patients and staff perspectives on the use of prophylactic dressingThe primary hypothesis is cumulative incidence (expressed as a percentage) of patients who develop sacral HAPI up to 14 days of admission will be less in patients who are randomly allocated to the routine care plus prophylactic silicone foam dressing group (intervention), compared to patients allocated to routine care only (control).The secondary hypothesis is patients in the prophylactic dressing group (intervention) will have better outcomes compared to the routine care only group (control) including (1) time to onset of sacral HAPI, (2) incidence of severity of sacral HAPI (based on stage), (3) cost-effectiveness of sacral dressings for the prevention of HAPI, and (4) process evaluation.